Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-751-6 | CAS number: 71-36-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
oral, LD50
rat ca. 2290 mg/kg bw (similar
OECD TG 401; Union Carbide Corporation 1967)
rat 2510 mg/kg/ bw (Jenner 1964)
rat 4360 mg/kg/bw female (Union Carbide Corporation 1951)
mouse 2680 mg/kg bw (Rumyanstev et al.,
1979, Val. 4)
rabbits 3500 mg/kg bw (Munch, 1972; Munch and Schwarze, 1925, Val. 4)
Golden hamsters 1200 mg/kg bw (Dubina and Maksimov, 1976, Val. 4)
Dogs, Minimum lethal dose: 1782 mg/kg bw (Von Oettingen, 1943, Val. 4)
dermal, LD50
rabbits ca. 3430 mg/kg bw (similar OECD 402, Union Carbide
Corporation 1951)
inhalation
rats (vapour) LC0 >= 17.76 mg/lL/ 4 h (similar OECD 403; BASF 1979)
rats (vapour) IHT, 21.48 mg/L: no mortality within 7 h (similar OECD
403; BASF 1980)
rats (vapour) LC0 > 24 mg/L/ 4 h; IHT: no mortality within 8 h (similar
to OECD 403; Union Carbide Corporation 1951)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1967
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- Test material was administered by oral gavage to rats at various dose levels. Survivors were observed for 14 days after dosing.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Harlan Wistar
- Sex:
- female
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- Dosage levels differ by a factor of 2 in a geometric series.
- No. of animals per sex per dose:
- Number of female rats used not stated in report but typically 6 rats are used/dose level.
- Control animals:
- not specified
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- ca. 2 292 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: converted value (calculated with a density 0.81 g/mL)
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2.83 mL/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: original value
- Interpretation of results:
- Category 5 based on GHS criteria
Reference
No additional information available.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 290 mg/kg bw
- Quality of whole database:
- similar OECD TG 401
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Principles of method if other than guideline:
- Rats (10 males and 10 females per dose) were exposed for 4 hours to 6.58 or 17.76 mg/l of the test substance. A dynamic inhalation method with whole-body exposure and with analytical and nominal determination of the concentration was used. The animals were observed for 14 days.
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: WIGA, Germany
- Weight at study initiation: 185 +- 15 g
- Housing: during exposure: 5 animals/cage
- Diet: ad libitum (food was withdrawn during the exposure)
- Water: ad libitum (water was withdrawn during the exposure)
ENVIRONMENTAL CONDITIONS
no data - Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Whole body inhalation system
- Exposure chamber volume: 200 L
- Method of holding animals in test chamber: animals are kept in wire mesh cages within the exposure chamber (5 animals/cage)
TEST ATMOSPHERE
- Brief description of analytical method used: samples were taken from the exposure chamber and analyzed via gaschromatography
- Samples taken from breathing zone: yes - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- via gaschromatography
- Duration of exposure:
- 4 h
- Concentrations:
- 6.58, 17.76 mg/L
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: the animal weight was determined before the start of the exposure, after 7 days and at the end of the observation period. The animals were checked daily for clinical signs and mortality
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- no data
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- > 17.76 mg/L air (analytical)
- Exp. duration:
- 4 h
- Remarks on result:
- other: highest concentration that could be generated
- Mortality:
- no deaths occured
- Clinical signs:
- other: none observed
- Body weight:
- Only marginal differences (slightly reduced weight gain) were observed between the treated groups and the control group. No dose dependency was observed.
- Gross pathology:
- no abnormalities detected
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 17 760 mg/m³ air
- Quality of whole database:
- similar OECD TG 403
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 7 June - 16 July 1951
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Principles of method if other than guideline:
- Test material was applied to the shaved skin of New Zealand albino rabbits for 24 hours. Survivors were examined for 14 days after dosing.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Male albino-New Zealand strain rabbits, 3 to 5 months of age and averaging 2.5 kg in weight were used.
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- Male albino New Zealand strain rabbits were immobilized during a 24-hour skin contact period. Thereafter, the "Vinylite" sheeting used to retain the dose in contact with the clipped skin of the trunk, was removed and the animals were caged for the remainder of the 14-day observation period.
- Duration of exposure:
- 24-hour
- Doses:
- 1.26, 2.52, 5.0 and 10.0 ml/kg
- No. of animals per sex per dose:
- 4 male/dose
- Control animals:
- not specified
- Details on study design:
- Groups of 4 male rabbits were dosed with 1.26, 2.52, 5.0 or 10 ml/kg for a 24 hour period. Survivors were observed for a 14 day observation period following dosing.
- Statistics:
- Thompson method of calculating the LD50 was used.
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 3 430 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: converted value (calculated with a density of 0.81 g/mL)
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4.24 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- 3.02 - 5.95
- Remarks on result:
- other: original value
- Mortality:
- All rabbits survived following a dose of 1.26 or 2.52 ml/kg. One rabbit survived following a dose of 5.0 ml/kg. All rabbits died following a dose of 10 ml/kg. All deaths occurred on the day of dosing.
- Clinical signs:
- other: No additional information available.
- Gross pathology:
- No additional information available.
- Other findings:
- No additional information available.
- Interpretation of results:
- Category 5 based on GHS criteria
Reference
No additional information available.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 434 mg/kg bw
- Quality of whole database:
- similar OECD TG 402
Additional information
Butan-1-ol is slightly acute toxic to experimental animals via the oral and dermal routes of exposure; a low acute toxicity was observed after inhalative exposure.
Oral
The most sensitive LD50 value was provided by a study comparable to OECD TG 401 (Union Carbide Corporation 1967). Here, 60 -day-old female Harlan Wistar rats were dosed with butan-1 -ol at various dose levels per gavage. The acute LD50 value was 2.83 mL/kg bw in female rats, corresponding to 2290 mg/kg bw (calculated with a density of 0.81 g/mL). No further data were available.
A comparable LD50 level was observed in a study following the standard acute method with acceptable restrictions (Jenner et al.1967). In this study, 5 young adult Osborne-Mendel rats per sex were dosed with butan-1-ol at different, but unspecified doses. The rats were observed for 14 days and the LD50 values were calculated. After 14 d observation period, the LD50 was 2510 mg/kg bw in rats. Mortality occurred within 4 -18 h after dosing, and depression and coma were reported as clinical signs. Weighing and performance of necropsy was not reported.
In another oral acute study, groups of 10 female rats were orally gavaged with 3160, 3980, 5000 or 6300 mg/kg and observed for 14 days after dosing. Here, 0, 3, 8 and 10 rats died at dose levels of 3160, 3980, 5000 or 6300 mg/kg, respectively. Deaths following oral doses occurred in many cases within 4 hours and in all but one instance within 24 hours. The LD50 was 4360 mg/kg/bw for female rats (Union Carbide Corporation 1951).
For other common test species oral LD50 values were reported with limited details: 2680 mg/kg bw for mice (Rumyanstev et al., 1979, Val. 4), 3500 mg/kg bw for rabbits (Munch, 1972; Munch and Schwarze, 1925, Val. 4), 1200 mg/kg bw for Golden hamsters (Dubina and Maksimov, 1976, Val. 4), and a minimum lethal dose of 1782 mg/kg bw for dogs (Von Oettingen, 1943, Val. 4). In the ECETOC JACC (2003) document also one publication with an oral LD50 in rats below 2000 mg/kg (790 mg/kg) is reported.
Dermal
The most reliable data were provided by a study comparable to OECD TG 402 (Union Carbide Corporation 1951). Here, butan-1 -ol was applied to the shaved skin of rabbits for 24 hours under occlusive conditions. Four doses of 1.26 to 10 ml/kg were applied to groups of four male rabbits and a LD50 value of 4.24 ml/kg bw (corresponding to ca. 3434 mg/kg bw; calculated with a density of 0.81 g/mL) was determined after an observation period of 14 days. Three rabbits of the 5 mL/kg bw group and all rabbits of the 10 ml/kg bw group died; all deaths occurred on the day of application. Body weight gain during the observation period was highly variable in the sublethal dose groups and negative in the survivor of the 5 mL/kg bw group. No information regarding clinical signs or local effects was available. In the ECETOC JACC (2003) document further dermal LD50 values in rabbits of 7600, 5300 and 4200 mg/kg are reported.
Inhalation
In a study similar to OECD TG 403, 10 Sprague-Dawley rats per sex per dose were whole-body exposed to vapour atmospheres of butan-1-ol for 4 h and observed for 14 d. The LC0 is >17.76 mg/L; no mortality or clinical signs were observed at 17.76 mg/L; only slightly reduced body weight gain was observed. Therefore, the LD50 level is considered to be > 20 mg/L (BASF 1979).
In another study, which was similar to the inhalation hazard test of OECD TG 403, 12 Sprague-Dawley rats of both sexes were exposed to a vapour saturated butan-1-ol atmosphere for 7 h. None of the animals died (BASF 1980).
Additionally, in a further study comparable to OECD TG 403 no mortalities were observed after exposure to a substantially saturated vapour for 8 hours in male rats and after exposure to 8000 ppm (ca. 24 mg/L) for 4 h in female rats, respectively. Poor coordination or prostration was observed in both trials (Union Carbide Corporation 1951).
Justification for classification or non-classification
Classification, Labeling, and Packaging Regulation (EC) No. 1272/2008
The substance is already listed in Annex VI to Regulation (EC) No 1272/2008 and classified with Cat. 4 oral (H302:" Harmful if swallowed"). Due to the slight dermal toxicity of butan-1-ol (rabbit LD50 ca. 3430 mg/kg bw), the substance has not to be classified according to Regulation (EC) No. 1272/2008, as amended for the ninth time in Regulation (EC) No 2016/1179.
Due to the very low inhalative toxicity of butan-1 -ol (rat 4h LC0 vapour >=17.76 mg/l), the substance is not considered to be classified for acute inhalative toxicity under Regulation (EC) No. 1272/2008, as amended for the ninth time in Regulation (EU) No 2016/1179.
Due to the observed local irritant effects on the respiratory system in an inhalation hazard test and in humans and transient effects on the CNS (drowsiness and dizziness) the substance is classified as STOT Single Exposure Cat. 3 (H335: "May causes respiratory irritation"/H336 "May cause drowsiness or dizziness") according to 1272/2008/EC (CLP) requirements.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.